Archives

by in
Entry Author Date Location
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
Will $28M in Debt Financing Push Good Start Genetics to Big Finish? 05/08/13 Boston
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Can Biotech Learn From the TV Production Market? 04/26/13 National
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
InVitae, Led by Randy Scott, Goes ‘All-in’ For Genomic Diagnostics 01/18/13 San Francisco
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments 08/15/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Page 1 of 4 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.